BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 16595711)

  • 1. Drug-drug interaction between pitavastatin and various drugs via OATP1B1.
    Hirano M; Maeda K; Shitara Y; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1229-36. PubMed ID: 16595711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
    Noé J; Portmann R; Brun ME; Funk C
    Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans.
    Ishiguro N; Maeda K; Kishimoto W; Saito A; Harada A; Ebner T; Roth W; Igarashi T; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1109-15. PubMed ID: 16611857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate-dependent inhibition of organic anion transporting polypeptide 1B1: comparative analysis with prototypical probe substrates estradiol-17β-glucuronide, estrone-3-sulfate, and sulfobromophthalein.
    Izumi S; Nozaki Y; Komori T; Maeda K; Takenaka O; Kusano K; Yoshimura T; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2013 Oct; 41(10):1859-66. PubMed ID: 23920221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-incubation with cyclosporine A potentiates its inhibitory effects on pitavastatin uptake mediated by recombinantly expressed cynomolgus monkey hepatic organic anion transporting polypeptide.
    Takahashi T; Ohtsuka T; Uno Y; Utoh M; Yamazaki H; Kume T
    Biopharm Drug Dispos; 2016 Nov; 37(8):479-490. PubMed ID: 27603548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans.
    Hirano M; Maeda K; Shitara Y; Sugiyama Y
    J Pharmacol Exp Ther; 2004 Oct; 311(1):139-46. PubMed ID: 15159445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The eighth and ninth transmembrane domains in organic anion transporting polypeptide 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17beta-D-glucuronide.
    Miyagawa M; Maeda K; Aoyama A; Sugiyama Y
    J Pharmacol Exp Ther; 2009 May; 329(2):551-7. PubMed ID: 19244099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins.
    Sharma P; Butters CJ; Smith V; Elsby R; Surry D
    Eur J Pharm Sci; 2012 Aug; 47(1):244-55. PubMed ID: 22538052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate.
    Zhang Y; Panfen E; Fancher M; Sinz M; Marathe P; Shen H
    Mol Pharm; 2019 Jun; 16(6):2342-2353. PubMed ID: 31039308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).
    Roth M; Araya JJ; Timmermann BN; Hagenbuch B
    J Pharmacol Exp Ther; 2011 Nov; 339(2):624-32. PubMed ID: 21846839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions.
    Izumi S; Nozaki Y; Maeda K; Komori T; Takenaka O; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2015 Feb; 43(2):235-47. PubMed ID: 25414411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
    Kunze A; Huwyler J; Camenisch G; Poller B
    Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.
    Treiber A; Schneiter R; Häusler S; Stieger B
    Drug Metab Dispos; 2007 Aug; 35(8):1400-7. PubMed ID: 17496208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction and Quantification of Hepatic Transporter-Mediated Uptake of Pitavastatin Utilizing a Combination of the Relative Activity Factor Approach and Mechanistic Modeling.
    Mitra P; Weinheimer S; Michalewicz M; Taub ME
    Drug Metab Dispos; 2018 Jul; 46(7):953-963. PubMed ID: 29666154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
    Kindla J; Müller F; Mieth M; Fromm MF; König J
    Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.
    Shitara Y; Takeuchi K; Nagamatsu Y; Wada S; Sugiyama Y; Horie T
    Drug Metab Pharmacokinet; 2012; 27(4):368-78. PubMed ID: 22240838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.
    Gui C; Miao Y; Thompson L; Wahlgren B; Mock M; Stieger B; Hagenbuch B
    Eur J Pharmacol; 2008 Apr; 584(1):57-65. PubMed ID: 18321482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 to hepatic uptake of nateglinide, and the prediction of drug-drug interactions via these transporters.
    Takanohashi T; Kubo S; Arisaka H; Shinkai K; Ubukata K
    J Pharm Pharmacol; 2012 Feb; 64(2):199-206. PubMed ID: 22221095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans.
    Shimizu M; Fuse K; Okudaira K; Nishigaki R; Maeda K; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2005 Oct; 33(10):1477-81. PubMed ID: 16014768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hepatic uptake transporters by flavonoids.
    Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
    Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.